Saturn V Capital Management as of Sept. 30, 2023
Portfolio Holdings for Saturn V Capital Management
Saturn V Capital Management holds 20 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Crinetics Pharmaceuticals In (CRNX) | 14.0 | $34M | 1.1M | 29.74 | |
| Kalvista Pharmaceuticals (KALV) | 7.3 | $17M | 1.8M | 9.63 | |
| Cogent Biosciences (COGT) | 7.2 | $17M | 1.8M | 9.75 | |
| Cymabay Therapeutics | 7.0 | $17M | 1.1M | 14.91 | |
| Biogen Idec (BIIB) | 7.0 | $17M | 65k | 257.01 | |
| Amylyx Pharmaceuticals (AMLX) | 6.8 | $16M | 886k | 18.31 | |
| Cytokinetics Com New (CYTK) | 6.1 | $15M | 495k | 29.46 | |
| Sarepta Therapeutics (SRPT) | 6.0 | $14M | 118k | 121.22 | |
| Horizon Therapeutics Pub L SHS | 5.4 | $13M | 111k | 115.69 | |
| Syndax Pharmaceuticals (SNDX) | 4.9 | $12M | 808k | 14.52 | |
| Iteos Therapeutics (ITOS) | 4.6 | $11M | 995k | 10.95 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 4.4 | $11M | 113k | 93.64 | |
| Anaptysbio Inc Common (ANAB) | 4.3 | $10M | 577k | 17.96 | |
| BioMarin Pharmaceutical (BMRN) | 4.1 | $9.7M | 110k | 88.48 | |
| Astria Therapeutics (ATXS) | 3.8 | $9.1M | 1.2M | 7.46 | |
| BioCryst Pharmaceuticals (BCRX) | 2.9 | $7.0M | 983k | 7.08 | |
| Argenx Se Sponsored Adr (ARGX) | 2.1 | $5.0M | 10k | 491.63 | |
| Morphic Hldg (MORF) | 1.3 | $3.1M | 137k | 22.91 | |
| Jasper Therapeutics | 0.4 | $971k | 1.4M | 0.70 | |
| Merus N V (MRUS) | 0.4 | $945k | 40k | 23.58 |
